Literature DB >> 34797445

External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.

Sara E Chapin1, David S Goldberg2, David E Kaplan3,4, Nadim Mahmud5,6,7,8.   

Abstract

BACKGROUND: The Freiburg index of post-TIPS survival (FIPS) score was recently demonstrated to improve prediction of post-TIPS mortality relative to existing standards. As this score was derived from a German cohort over an extended time period, it is unclear if performance will translate well to other settings. This study aimed to externally validate the FIPS score in a large Veterans Affairs (VA) cohort over two separate eras of TIPS-related care.
METHODS: This was a retrospective cohort study of patients with cirrhosis who underwent TIPS placement in the VA from 2008 to 2020. Cox regression models for post-TIPS survival were constructed using FIPS, MELD, MELD-Na, or CTP scores as predictors. Discrimination (Harrell's C) and calibration (joint tests of calibration curve slope and intercept) were evaluated for each score. A stratified analysis was performed for time periods between 2008-2013 and 2014-2020.
RESULTS: The cohort of 1,274 patients was 97.3% male with mean age 60.9 years and mean MELD-Na 14. The FIPS score demonstrated the highest overall discrimination versus MELD, MELD-Na, and CTP (0.634 vs. 0.585, 0.626, 0.612, respectively). However, in the modern treatment era (2014-2020), the FIPS score performed similarly to MELD-Na. Additionally, the FIPS score demonstrated poor calibration at one-month and six-month post-TIPS timepoints (joint p = 0.04 and 0.004, respectively). MELD, MELD-Na, and CTP were well-calibrated at each timepoint (each joint p > 0.05).
CONCLUSION: The FIPS score performed similarly to MELD-Na in the modern TIPS treatment era and demonstrated regions of poor calibration. Future models derived with contemporary data may improve prediction of post-TIPS mortality.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cirrhosis; FIPS; MELD-Na; Prediction modeling; TIPS

Mesh:

Substances:

Year:  2021        PMID: 34797445      PMCID: PMC9117561          DOI: 10.1007/s10620-021-07307-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  33 in total

1.  External validation of the freiburg index of post-TIPS survival.

Authors:  Frederik Kraglund; Rasmus Hvidbjerg Gantzel; Peter Jepsen; Niels Kristian Aagaard
Journal:  J Hepatol       Date:  2021-04-26       Impact factor: 25.083

2.  Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS?

Authors:  Lena Stockhoff; Hannah Schneider; Tammo Lambert Tergast; Markus Cornberg; Benjamin Maasoumy
Journal:  J Hepatol       Date:  2021-03-12       Impact factor: 25.083

3.  The underdilation of nitinol stents at TIPS implantation: Solution or illusion?

Authors:  Ashkan Mollaiyan; Dominik Bettinger; Martin Rössle
Journal:  Eur J Radiol       Date:  2017-02-01       Impact factor: 3.528

4.  Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis.

Authors:  Nadim Mahmud; David E Kaplan; Tamar H Taddei; David S Goldberg
Journal:  Hepatology       Date:  2019-03-20       Impact factor: 17.425

5.  Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.

Authors:  David E Kaplan; Feng Dai; Ayse Aytaman; Michelle Baytarian; Rena Fox; Kristel Hunt; Astrid Knott; Marcos Pedrosa; Christine Pocha; Rajni Mehta; Mona Duggal; Melissa Skanderson; Adriana Valderrama; Tamar H Taddei
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

6.  MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  Francesco Salerno; Manuela Merli; Massimo Cazzaniga; Valentina Valeriano; Plinio Rossi; Andrea Lovaria; Daniele Meregaglia; Antonio Nicolini; Lorenzo Lubatti; Oliviero Riggio
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

7.  Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.

Authors:  Christophe Bureau; Dominique Thabut; Frédéric Oberti; Sébastien Dharancy; Nicolas Carbonell; Antoine Bouvier; Philippe Mathurin; Philippe Otal; Pauline Cabarrou; Jean Marie Péron; Jean Pierre Vinel
Journal:  Gastroenterology       Date:  2016-09-20       Impact factor: 22.682

8.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

9.  Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.

Authors:  Brian T Lee; Alexander H Yang; Seth Urban; Ki-Yoon Kim; Ramon Ter-Oganesyan; Liyun Yuan; Hyosun H Han; Saro Khemichian; Jeffrey A Kahn; Brian Kim
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-04-01       Impact factor: 2.566

10.  Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.

Authors:  Michael Schepke; Felix Roth; Rolf Fimmers; Karl August Brensing; Thomas Sudhop; Hans H Schild; Tilman Sauerbruch
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.